MissouriModifies provisions relating to alternative therapies
What it does
This act modifies current law on the use of investigational drugs and devices for individuals with terminal illnesses to include those individuals with life-threatening or severely debilitating conditions or illnesses.
More detail
Currently, investigational drugs shall not include Schedule I controlled substances. This act repeals that prohibition.
This act is substantially similar to provisions in SB 1682 (2026, SCS/SB 90 (2025), SB 1767 (2026), SCS/HCS/HBs 1717 & 1643 (2026), SCS/HS/HCS/HBs 3068 & 3049 (2026), and SCS/SB 768 (2024). SARAH HASKINS
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed Senate
- Passed House
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2026
- Feb 5Second Read and Referred S Families, Seniors and Health CommitteeLatest
- Jan 7S First ReadMinor
- 2025
- Dec 19PrefiledIntroduced